Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Marinus Pharmaceuticals Inc (MRNS)  
$1.41 0.01 (1.06%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 55,671,000
Market Cap: 78.22(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.2 - $11.21
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Marinus Pharmaceuticals is a pharmaceutical company focused on developing and commercializing products for patients suffering from rare genetic epilepsies and other seizure disorders. The U.S Food and Drug Administration approved the use of ZTALMY® (ganaxolone) oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder in patients two years of age and older. Ganaxolone is being developed in formulations for various routes of administration: intravenous and oral. Ganaxolone acts at both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors, a target known for its anti-seizure, antidepressant and anxiolytic potential.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,803 21,803 38,528 41,369
Total Sell Value $215,409 $215,409 $374,962 $393,504
Total People Sold 5 5 5 8
Total Sell Transactions 5 5 15 18
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 129
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Vitullo Nicole Director   –       •       •   2016-08-03 4 A $0.00 $0 D/D 3,300 3,300     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-08-03 4 S $1.50 $213,381 I/I (142,254) 2,003,266     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-07-29 4 S $1.71 $41,963 I/I (24,540) 2,145,520     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-07-27 4 S $1.80 $376 I/I (209) 2,170,060     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-07-26 4 S $1.81 $36,888 I/I (20,380) 2,170,269     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-07-25 4 S $1.86 $255,968 I/I (137,617) 2,190,649     -
   Canaan Partners Vii Llc 10% Owner   –       –       •   2016-07-22 4 S $1.94 $258,278 I/I (133,133) 2,328,266     -
   Cashman Christopher Michael President and CEO   •       •      –    2016-02-09 4 OE $1.04 $25,671 D/D 24,684 140,769     -
   Cashman Christopher Michael President and CEO   •       •      –    2015-11-06 4 B $5.61 $19,977 D/D 3,561 116,085 2.81     -
   Bloch Stephen M Director   –       •      –    2015-09-28 4 OE $1.04 $41,132 D/D 39,550 39,550     -
   Mayleben Timothy M Director   –       •      –    2015-07-16 4 OE $1.04 $44,252 D/D 42,550 42,550     -
   Cashman Christopher Michael President and CEO   •       •      –    2015-07-01 4 OE $1.04 $14,649 D/D 14,086 112,524     -
   Bloch Stephen M Director   –       •      –    2015-06-10 4 GD $0.00 $0 D/D 3,000 0     -
   Bloch Stephen M Director   –       •      –    2015-06-10 4 OE $1.04 $3,120 D/D 3,000 3,000     -
   Farfel Gail M Chief Clinical Dev & Reg Offic   •       –      –    2015-04-21 4 AS $9.48 $284,511 D/D (30,000) 0     -
   Farfel Gail M Chief Clinical Dev & Reg Offic   •       –      –    2015-04-21 4 OE $1.04 $31,200 D/D 30,000 30,000     -
   Cashman Christopher Michael PRESIDENT AND CEO   •       •      –    2015-03-06 4 OE $1.04 $18,312 D/D 17,608 98,438     -
   Shah Nimesh 10% Owner   –       –       •   2015-01-01 3 IO $0.00 $0 I/I 0 42,550     -
   Cashman Christopher Michael PRESIDENT AND CEO   •       •      –    2014-10-08 4 OE $1.04 $84,063 D/D 80,830 80,830     -
   Vitullo Nicole Director   –       •       •   2014-08-05 4 A $0.00 $0 D/D 17,000 17,000     -
   Vitullo Nicole Director   –       •       •   2014-08-05 4 B $8.00 $3,357,952 D/D 419,744 2,476,886 3.92     -
   Vitullo Nicole Director   –       •       •   2014-08-05 4 A $0.00 $0 D/D 2,057,142 2,057,142     -
   Powell Michael 10% Owner   –       –       •   2014-08-05 4 B $8.00 $6,005,464 I/I 750,683 27,998 1.5     -
   Powell Michael 10% Owner   –       –       •   2014-08-05 4 A $0.00 $0 I/I 1,375,166 15,470     -
   Canaan Partners Vii Llc Director   –       •       •   2014-08-05 4 B $8.00 $5,000,000 I/I 625,000 2,461,398 2.25     -
  129 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us